Financials
Financial year 2025
DR. JESPERS JOHAN from Genk, company number BE0473368116, closed financial year 2025 with a result of € 73,682 after tax. For that financial year DR. JESPERS JOHAN recorded a gross margin of € 113,461 and equity of € 557,756. Compared with financial year 2024, the result moved from € 60,397 to € 73,682. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on September 30, 2026.
€ 557,756
▲ 15% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 73,682
▲ 22% vs 2024
Profit after tax over the fiscal year.
€ 70,754
▲ 31% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 537,756.
People and assets in 2025
€ 8,817
▲ € 7,243 vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 5,771
▲ € 4,963 vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 4,256
▼ 88% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 72,946 | € 105,715 | € 104,398 | € 113,461 | ▲ 9% |
| Profit after taxes | € 42,345 | € 61,680 | € 60,397 | € 73,682 | ▲ 22% |
| Equity | € 429,732 | € 486,621 | € 484,074 | € 557,756 | ▲ 15% |
| Total debts | € 59,766 | € 53,253 | € 44,535 | € 10,027 | ▼ 77% |
| Cash | € 31,732 | € 22,233 | € 54,010 | € 70,754 | ▲ 31% |
| Land & buildings | € 60,326 | € 58,360 | € 44,829 | € 31,325 | ▼ 30% |
| Retained profit | € 409,732 | € 466,621 | € 464,074 | € 537,756 | ▲ 16% |
| Dividend | € 1,600 | € 4,791 | € 62,944 | € 0 | ▼ 100% |
| Bank debt | € 0 | € 0 | € 8,557 | € 0 | ▼ 100% |
| Balance sheet total | € 489,498 | € 539,874 | € 528,608 | € 567,782 | ▲ 7% |
Key figures of DR. JESPERS JOHAN, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to DR. JESPERS JOHAN?
What happened at DR. JESPERS JOHAN in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Johan Jespers stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 73,682 (▲ 22% vs 2024). filed late Source: NBB ↗
- New establishment in Genk. KBO
- Start of the company according to the CBE. KBO
- Johan Jespers became a director. NBB
In short
From € 42,345 profit in 2022 to € 73,682 profit in 2025.
Paid € 117,430 in corporate taxes since 2022.
Best year ever: 2025, with € 73,682 profit.
Paid out € 69,335 in dividends to the owners in total.
Management
It owns 33.3% of Heideveld and 16% of IMMO Heideveld itself.
Directors
According to the 2025 annual accounts
Johan Jespers
Director
Also active at: Limburgse Dienst voor Stem- en Spraaktherapie, REVA Kohesi, De Schans, Beschut Wonen Kohesi, CGG Kohesi
since 2000 · until 2040
Establishments
Establishment units
Physical locations of this company
Reinpadstraat 125
3600 Genk
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0473.368.116
- VAT number
- BE 0473.368.116
- Registered office
- Reinpadstraat 125, 3600 Genk
- Names & denominations
- DR. JESPERS JOHAN
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 28 November 2000
- Peppol
- Active · Active since 6 Jan 2026
- Activities · NACE
Activiteiten van medisch specialisten